Caryn McDowell
Nessuna posizione attualmente
Profilo
Caryn G.
McDowell formerly worked at Affymax, Inc., as Executive Director-Corporate Law from 2012 to 2013, Onyx Pharmaceuticals, Inc., as Associate General Counsel & Head-US Healthcare Law in 2013, InterMune, Inc., as SVP, Deputy General Counsel & Assistant Secretary from 2014 to 2015, Cytokinetics, Inc., as Chief Compliance Officer & General Counsel from 2016 to 2018, Revance Therapeutics, Inc., as Secretary, Senior VP & General Counsel, State of Massachusetts, as Assistant Attorney General-Medicaid Fraud Control, US Department of Health & Human Services (DC), as Senior Counsel-Inspector General Office from 2001 to 2004, and Quince Therapeutics, Inc., as Secretary, Chief Administrative & Legal Officer from 2020 to 2022.
Ms. McDowell received her undergraduate degree from the University of Michigan and graduate degree from Boston University School of Law.
Precedenti posizioni note di Caryn McDowell
| Società | Posizione | Fine |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Direttore Amministrativo | 08/07/2022 |
| CYTOKINETICS, INCORPORATED | Responsabile della Conformità | 01/05/2018 |
| INTERMUNE INC | Corporate Officer/Principal | 01/02/2015 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Consigliere Generale | 01/12/2013 |
| AFFYMAX, INC. | Consigliere Generale | 01/01/2013 |
Formazione di Caryn McDowell
| University of Michigan | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| AFFYMAX, INC. | Health Technology |
| REVANCE THERAPEUTICS, INC. | Health Technology |
| QUINCE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
| US Department of Health & Human Services (DC) | Government |
| State of Massachusetts | Government |
- Borsa valori
- Insiders
- Caryn McDowell
